Alcobra Ltd. (ADHD) Enrolls First Patient in MDX Phase IIb for Fragile X Syndrome
Tweet Send to a Friend
Alcobra Ltd. (Nasdaq: ADHD) announced that the first patient has been enrolled in a Phase IIb Fragile X study of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
